Johnson Matthey provides superior products and services to the Pharmaceutical and Fine Chemical sectors. Our business units include: Johnson Matthey Pharmaceutical Services (JMPS) headquartered in Devens, MA, houses state-of-the-art, self-contained manufacturing suites featuring 100-500 gallon glass-lined and hastelloy reactors with cryogenic cooling capabilities. The facility also features more than 30 kilo-laboratories including a dedicated high-potency lab and a catalytic screening laboratory. Our second site, located in North Andover, Massachusetts, houses three additional reactor trains and a separations technology facility. JMPS is unique in that it can offer you whatever you need every step of the way, including a full range of analytical and regulatory services. The Catalysis & Chiral Technologies (CCT) unit of Johnson Matthey’s Fine Chemicals & Catalyst Division located in West Deptford, NJ, provides superior catalytic solutions to the pharmaceutical, fine chemical, agrochemical, and nutraceutical markets. We offer a unique collection of chiral ligands for asymmetric hydrogenation as well as a complementary line of novel carbonyl reductases enzyme technology, novel palladium coupling catalysts, Platinum Group Metal (PGM)-based heterogeneous catalysts, and Sponge Nickel(TM) catalysts. Our optimization services include catalyst process development (multi-step syntheses), knowledge-based selection, purification technology (Smopex®), and process scale-up. Johnson Matthey Pharmaceutical Materials (JMPM), USA’s bulk cGMP API facility located in West Deptford, NJ is home to hastelloy and glass-lined reactor trains ranging in capacity up to 2,000 gallons (7,600L). The facility is in strict compliance with DEA manufacturing requirements for Schedule I through IV controlled substances and houses Class 100,000 contamination-controlled rooms with HEPA-filtered air-handling systems.
